Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies

Slični predmeti

• Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
  od: Frontiers Production Office
  Izdano: (2024-01-01)
• Antimicrobial Efficacy of Cefoperazone-Salbactam Plus Tigecycline versus Cefoperazone-Salbactam Against Respiratory Pathogens and Their Effect on Laboratory Indices
  od: Sundas Shaukat, i dr.
  Izdano: (2023-07-01)
• Risk Factors for Cefoperazone/Sulbactam-Induced Coagulation Disorder
  od: Miao W, i dr.
  Izdano: (2023-09-01)
• Coagulopathy Induced by Cefoperazone/Sulbactam in a Geriatric Patient
  od: Ergenekon Karagoz, i dr.
  Izdano: (2015-12-01)
• The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model
  od: Changjing Xu, i dr.
  Izdano: (2025-01-01)